Yes, most employer-sponsored healthcare benefits cover prescription drugs, but how they're covered depends on your plan design. In traditional BUCA (Blues, United, Cigna, Aetna) plans and self-funded arrangements, drug coverage usually sits inside the medical benefit, though a separate Pharmacy Benefit Manager (PBM) often runs it. Copayments, the fixed dollar amount you pay at the pharmacy, are set by the plan's drug formulary, which sorts medications into tiers based on cost, clinical effectiveness, and whether the drug is generic, brand-name, or specialty.
How Prescription Drug Coverage Works in Employer Health Plans
Most health plans handle drug coverage one of two ways:
- Integrated – The pharmacy benefit is bundled with the medical plan, using a single deductible and out-of-pocket max. Common in HMO and PPO plans.
- Carved out – The drug benefit runs separately, often with its own deductible and copay structure. Frequent in self-funded plans that want tighter control over pharmacy spend via a PBM.
Either way, the Affordable Care Act (ACA) requires non-grandfathered individual and small group plans to cover prescription drugs as one of 10 essential health benefits. Large employers and self-funded plans don't face that requirement, though nearly all of them cover drugs anyway. The rule that a plan must cover at least one drug in each of six protected classes (antidepressants, antipsychotics, anticonvulsants, antineoplastics, antiretrovirals, and immunosuppressants) comes from Medicare Part D, not the ACA. The specific drugs covered, and what you pay for them, are up to the plan sponsor and their PBM.
How Copayments Are Determined
Copayments aren't random. They come from a structured process centered on the plan's formulary, a list of preferred medications organized into tiers:
- Tier 1 (Generic drugs) – Lowest copay, often $5–$15. Chemically identical to brand-name, but far cheaper.
- Tier 2 (Preferred brand-name drugs) – Moderate copay, typically $30–$60. The PBM has negotiated a lower price for these.
- Tier 3 (Non-preferred brand-name drugs) – Higher copay, often $60–$120. No negotiated discount.
- Tier 4 (Specialty drugs) – Highest copay, sometimes 20–30% coinsurance. Includes biologics and high-cost drugs for conditions like rheumatoid arthritis or cancer.
Employers can customize these tiers, and many lean on copay accumulator programs or maximum allowable cost (MAC) lists to manage spend. A copay accumulator stops manufacturer copay assistance from counting toward a member's deductible, while a MAC list caps what the plan pays for interchangeable generics. Some plans also apply a deductible before copays kick in, especially for Tier 3 and Tier 4 drugs, where coinsurance (a share of the drug's price rather than a flat fee) is common.
When Higher Copays Backfire
Raising copays is the standard cost-shifting move, and it looks like savings on paper. In practice, about 1 in 3 Americans skip care or prescriptions because of cost. When an employee skips a statin or an insulin dose to avoid a copay, the plan doesn't save money. The plan then pays for the emergency room visit or hospital stay that follows. Skipped maintenance medications produce avoidable complications and higher total claims, which is why some employers cut copays on the drugs that keep people healthy. The savings show up downstream, in fewer catastrophic claims rather than a higher charge at the counter.
WellthCare's Approach: Replacing the PBM With Aligned Incentives
Traditional copay structures often hide misaligned incentives. PBMs profit from spread pricing and rebates, which can inflate costs for both employers and employees. WellthCare Pharmacy™, part of the broader WellthCare ecosystem, replaces that opaque system with transparent, aligned pricing. WellthCare is the first Health-to-Wealth Benefit System, integrating transparent pharmacy pricing with preventive health rewards that pay employees back for every verified action. By integrating pharmacy with preventive health incentives, like earning reward dollars at the WellthCare Store™ for medication adherence, employees pay less out-of-pocket, and employers see 20–40% savings on drug costs.
In a WellthCare plan, the incentive points the other way. Verified preventive actions earn reward dollars at the WellthCare Store™, and $0-co-pay care is used before the primary plan, so members keep more of what they would otherwise spend at the pharmacy. Stick to a medication schedule and that value compounds in the account. That's a system that rewards prevention, not illness. Traditional copay models can't say the same.
Key Takeaways for Employers
- Prescription drug coverage is almost always part of healthcare benefits, but cost-sharing varies.
- Copayments are set by the formulary tiers and shaped by PBM contracts.
- Lowering employee copays on high-value preventive or maintenance drugs (statins, insulin) improves adherence and cuts total claims cost.
- Auditing your PBM for transparency, like WellthCare Pharmacy™ does, can uncover 20–40% savings without shifting costs to employees.
When you understand how copayments are set, you can redesign benefits that cut waste, boost health, and build long-term value. That's the heart of the Health-to-Wealth™ philosophy.